Home › NDC Lookup › RxCUI directory › RxCUI 830879

24 HR diltiazem hydrochloride 240 MG Extended Release Oral Tablet — RxCUI 830879

RxNorm drug concept · Semantic clinical drug
RxCUI 830879 Semantic clinical drug · SCD ● Current RxNorm concept 35 FDA products 70 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI830879
Official name24 HR diltiazem hydrochloride 240 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdilTIAZem hydrochloride 240 MG 24HR Extended Release Oral Tablet
FDA products mapped35
Package NDCs mapped70
Reported Medicaid activity (SDUD)7,839 prescriptions · 22 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Diltiazem: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Diltiazem is used for a few different heart and blood vessel conditions depending on the form you have. The oral extended-release tablets and capsules treat high blood pressure and...
  • It depends on the specific product you have. Extended-release tablets like Matzim LA or Cardizem LA can be taken with or without food — food doesn't meaningfully affect their absor...
  • Does it matter what time of day I take diltiazem, or whether I take it with food?
  • No — please don't do that with extended-release forms of diltiazem. Crushing, chewing, or opening an extended-release capsule or tablet destroys the time-release mechanism, which m...
📖 Read our full Diltiazem guide →

🕸️ Concept Web — How 24 HR diltiazem hydrochloride 240 MG Extended Re... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR diltiazem hydrochloride 240 MG Extended Release Oral Tablet RxCUI 830879

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Diltiazem 3443
    • Diltiazem hydrochloride 203211
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Cardizem 203494
    • Matzim 1091620
  3. Dose forms 17

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Diltiazem Extended Release Oral Tablet 375031
    • Diltiazem hydrochloride Extended Release Oral Tablet 2645878
    • Diltiazem Oral Product 1151888
    • Diltiazem Pill 1151889
    • Diltiazem hydrochloride Oral Product 2659741
    • Diltiazem hydrochloride Pill 2659131
    • Diltiazem Extended Release Oral Tablet [Cardizem] 830875
    • Diltiazem Extended Release Oral Tablet [Matzim] 1091622
    • +9 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 17 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Diltiazem hydrochloride 240 MG SCDC · 830836
  • Diltiazem Extended Release Oral Tablet SCDF · 375031
  • Diltiazem hydrochloride Extended Release Oral Tablet SCDFP · 2645878
  • Diltiazem Oral Product SCDG · 1151888
  • Diltiazem Pill SCDG · 1151889
  • Diltiazem hydrochloride Oral Product SCDGP · 2659741
  • Diltiazem hydrochloride Pill SCDGP · 2659131

Brand-Name Concepts

📦 FDA Products & Package NDCs

35 products · 70 package NDCs
70 package NDCs map to RxCUI 830879 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
69097-0994-02 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-994-02) DILTIAZEM HYDROCHLORIDE Cipla USA, Inc. 2023-06-12
69097-0994-05 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-994-05) DILTIAZEM HYDROCHLORIDE Cipla USA, Inc. 2023-06-12
69097-0995-02 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-995-02) DILTIAZEM HYDROCHLORIDE Cipla USA, Inc. 2023-06-12
69097-0995-05 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-995-05) DILTIAZEM HYDROCHLORIDE Cipla USA, Inc. 2023-06-12
69097-0996-02 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-996-02) DILTIAZEM HYDROCHLORIDE Cipla USA, Inc. 2023-06-12
69097-0996-05 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-996-05) DILTIAZEM HYDROCHLORIDE Cipla USA, Inc. 2023-06-12
69097-0997-02 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-997-02) DILTIAZEM HYDROCHLORIDE Cipla USA, Inc. 2023-06-12
69097-0997-05 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-997-05) DILTIAZEM HYDROCHLORIDE Cipla USA, Inc. 2023-06-12
70436-0195-04 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-195-04) Diltiazem Hydrochloride Slate Run Pharmaceuticals, LLC 2023-03-20
70436-0195-06 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-195-06) Diltiazem Hydrochloride Slate Run Pharmaceuticals, LLC 2023-03-20
70436-0196-04 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-196-04) Diltiazem Hydrochloride Slate Run Pharmaceuticals, LLC 2023-03-20
70436-0196-06 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-196-06) Diltiazem Hydrochloride Slate Run Pharmaceuticals, LLC 2023-03-20
70436-0197-04 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-197-04) Diltiazem Hydrochloride Slate Run Pharmaceuticals, LLC 2023-03-20
70436-0197-06 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-197-06) Diltiazem Hydrochloride Slate Run Pharmaceuticals, LLC 2023-03-20
70436-0198-04 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-198-04) Diltiazem Hydrochloride Slate Run Pharmaceuticals, LLC 2023-03-20
70436-0198-06 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-198-06) Diltiazem Hydrochloride Slate Run Pharmaceuticals, LLC 2023-03-20
70436-0199-04 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-199-04) Diltiazem Hydrochloride Slate Run Pharmaceuticals, LLC 2023-03-20
70436-0199-06 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-199-06) Diltiazem Hydrochloride Slate Run Pharmaceuticals, LLC 2023-03-20
70436-0200-04 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-200-04) Diltiazem Hydrochloride Slate Run Pharmaceuticals, LLC 2023-03-20
70436-0200-06 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-200-06) Diltiazem Hydrochloride Slate Run Pharmaceuticals, LLC 2023-03-20
Observed labelers: Bausch Health US LLC (12) · Cipla USA, Inc. (12) · Oceanside Pharmaceuticals (12) · ScieGen Pharmaceuticals, Inc. (12) · Slate Run Pharmaceuticals, LLC (12) · Actavis Pharma, Inc. (10) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.